Open-label, Investigator-Initiated, Single Site Exploratory Trial Evaluating Secukinumab, an anti IL17A monoclonal antibody, for Patients with Moderate-to-Severe Hidradenitis Suppurativa.

This article is protected by copyright. All rights reserved.
PMID: 30801662 [PubMed - as supplied by publisher]

Source: The British Journal of Dermatology - February 22, 2019 Category: Dermatology Authors: Prussick L, Rothstein B, Joshipura D, Saraiya A, Turkowski Y, Abdat R, Alomran A, Zancanaro P, Kachuk C, Dumont N, Gottlieb AB, Rosmarin D Tags: Br J Dermatol Source Type: research